Barclays analyst Lauren Lieberman lowered the firm’s price target on Clorox to $108 from $110 and keeps an Underweight rating on the shares. Even after a big fiscal Q2 earnings beat, Clorox’s full year outlook is reasonable, "not excessively conservative," the analyst tells investors in a research note.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CLX:
